Market Currents
Arena Pharmaceuticals (ARNA) +4.3% amid heavy trading and continuing the upward trend it's...
-
Tuesday, July 10, 2012, 1:35 PM ETArena Pharmaceuticals (ARNA) +4.3% amid heavy trading and continuing the upward trend it's enjoyed since April over excitement about its Belviq obesity treatment. SA author Efsinvestment says that with a Relative Strength Index of 65%, the stock needs a breather, although it will be worth buying after any pullback.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments: